Literature DB >> 6298326

[Evaluation of intratumoral injection of an immunopotentiator (OK-432) in patients with hepatocellular carcinoma].

S Imaoka, Y Sasaki, Y Matsui, O Ishikawa, K Taniguchi, T Iwanaga, T Terasawa.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 6298326

Source DB:  PubMed          Journal:  Nihon Gan Chiryo Gakkai Shi        ISSN： 0021-4671


× No keyword cloud information.
  2 in total

1.  New therapy complementary to transcatheter arterial embolization for hepatocellular carcinoma.

Authors:  R Yamada; K Nakamura; N Nishida; T Matsuoka; K Yamada; K Tanaka; M Terada; M Sato
Journal:  World J Surg       Date:  2001-04-11       Impact factor: 3.352

2.  The clinical efficacy of intratumoral OK-432 administration in advanced cancer patients.

Authors:  T Toge; H Kuninobu; Y Yamaguchi; N Baba; Y Kegoya; T Hattori
Journal:  Jpn J Surg       Date:  1988-11
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.